Cullen/Frost Bankers’s Qiagen QGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$336 Hold
9
﹤0.01% 1359
2026
Q1
$344 Sell
9
-966
-99% -$45.7K ﹤0.01% 1339
2025
Q4
$43.9K Buy
975
+74
+8% +$3.42K ﹤0.01% 825
2025
Q3
$40.3K Sell
901
-291
-24% -$13.9K ﹤0.01% 792
2025
Q2
$57.3K Buy
1,192
+1,183
+13,144% +$51.5K ﹤0.01% 736
2025
Q1
$361 Sell
9
-1
-10% -$42 ﹤0.01% 1263
2024
Q4
$445 Hold
10
﹤0.01% 1296
2024
Q3
$456 Buy
+10
New +$456 ﹤0.01% 1188

Other funds holding QGEN

Cullen/Frost Bankers's QGEN Position: Q2 2026 in Review

Cullen/Frost Bankers held its Qiagen (QGEN) position steady in Q2 2026 at 9 shares worth $336. The position accounts for ﹤0.01% of the portfolio, ranked #1359.

Cullen/Frost Bankers first reported a position in QGEN in Q3 2024 and has held it in 8 quarters since. The position peaked at $57.3K in Q2 2025. 336 funds tracked by Wall St. Rank hold QGEN as of Q2 2026.

  • Cullen/Frost Bankers held 9 shares of Qiagen worth $336 as of Q2 2026.
  • Cullen/Frost Bankers left its Qiagen share count unchanged in Q2 2026.
  • Qiagen made up ﹤0.01% of Cullen/Frost Bankers's portfolio in Q2 2026, its #1359 holding.
  • Cullen/Frost Bankers first reported a position in Qiagen in Q3 2024 and has held it in 8 quarters since.
  • Cullen/Frost Bankers's Qiagen position peaked at $57.3K in Q2 2025.
  • 336 funds tracked by Wall St. Rank held Qiagen as of Q2 2026.

Based on Cullen/Frost Bankers's 13F filing for Q2 2026, filed 27 Jul 2026.